Warning about inactivated economic and social costs, experts say there is a need for better control, treatment and public education to end weaning.
More than 10 million people are registered during the year than those cases of lung disease. Consumption of a infectious disease that most people die today – more than 1.6 million. over a year, although this condition can be stopped, and it is usually cured when found.
"This is a huge problem and its economic burden on developing and developing countries is remarkable," said Eric Goosby, United Nations Special Envoy to the AFP newsgroup.
"It's not rock science, it is really sympathetic. We need to start a new prevention strategy," he said.
The consumption has existed for thousands of years, but the representative producers are in around a quarter of humanity.
Although almost all people are killed every year with HIV / AIDS and malaria compiled, there is no new vaccine to get out for centuries.
Currently, only around 10% of spend is currently treated. compared with the amount spent on AIDS research.
Experts from 13 states in The Lancet magazine said funding for the research into spend and development of handling techniques should be made four times up to around $ 3 billion. $ 2.64 billion a year.
In India, where a third of the world's deaths are recorded, a better chance of handling and targeted measures can be reduced to reduce the number of deaths among groups t the risk of almost a third, with an annual sum of € 290 million. dollar (EUR 255.4 million). t
These figures can be compared with $ 32 billion. $ 28 billion in annual economic loss, including medical expenses and wear-related productivity.
“The real thing is that we need lots of new research and new tools,” said Paula Fujiwara (Pola Fujawara), director of the Paris-based International Union against consumption and disease. lungs.
“Even though we use today's equipment, it will not be enough. The aim is to put an end to spending, but this reduction is now 1.5-2%. , "AFP said.
An Lancet article says that although the medical methods currently available are up and running at 90%. people with wear and tear, 800,000 patients are still dying – this is due to ineffectiveness of procedures and gaps in judgment.
The recent achievements in recent months have been given to patients.
In October, a new way of dealing with tuberculosis was treated with 80 per cent. patients in Belarus. After that, such treatment was used in other countries with high levels of spending. The results were similar.
Earlier month, GlaxoSmithKline, a vet, administered a check which showed that one new vaccine was effective at 54%. exam partners.
And doctors say one new method of research will help to reduce the number of children under five who are currently dying to die at 240,000. every year.
According to Goosby, further tests are required to continue. "It is inevitable that we will need new medicines as the disease is coming." – As a global health campaign, we should wait to expect strength (drug development) and keep working.
The Lancet article says that death reduction is less than 200,000. the annual yield rate would be about EUR 10 billion. $ 8.8 billion a year.
It's not a copy of the BNS.